Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -102.40% is in line with its 5-year average of -104.53%, around the middle of its 5-year range (-229.92%–-37.67%).
As of the fiscal period ended Tuesday, June 30, 2026. 41.05% below its 12-month average of -72.60%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -102.40%.
RETURN ON EQUITY (ROE)
-102.40%
RETURN ON EQUITY (ROE) AVG TTM
-72.60%
RETURN ON EQUITY (ROE) AVG 3Y
-118.83%
RETURN ON EQUITY (ROE) AVG 5Y
-104.53%
RETURN ON EQUITY (ROE) AVG 10Y
-111.71%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-41.05%
CURRENT VS 3Y AVG
+13.83%
CURRENT VS 5Y AVG
+2.04%
CURRENT VS 10Y AVG
+8.33%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-143.74%
vs the sector median at left
Phio Pharmaceuticals Corp.
Market Cap
$11.29M
Return on Equity (ROE)
-102.40%
TTM Avg
-72.60%
3Y Avg
-118.83%
5Y Avg
-104.53%
Market Cap
$11.75M
Return on Equity (ROE)
-106.87%
TTM Avg
-250.57%
3Y Avg
-230.96%
5Y Avg
-240.83%
Market Cap
$12.03M
Return on Equity (ROE)
-97.47%
TTM Avg
-90.15%
3Y Avg
-205.18%
5Y Avg
-136.35%
Market Cap
$11.22M
Return on Equity (ROE)
-477.54%
TTM Avg
-207.60%
3Y Avg
64.51%
5Y Avg
-22.91%
Market Cap
$11.27M
Return on Equity (ROE)
-506.63%
TTM Avg
-300.20%
3Y Avg
-300.20%
5Y Avg
-300.20%
Market Cap
$11.19M
Return on Equity (ROE)
-276.21%
TTM Avg
-134.62%
3Y Avg
-196.35%
5Y Avg
-146.45%
Market Cap
$11.01M
Return on Equity (ROE)
-214.92%
TTM Avg
-46.13%
3Y Avg
-156.76%
5Y Avg
-652.77%
Market Cap
$11.12M
Return on Equity (ROE)
-65.18%
TTM Avg
-26.62%
3Y Avg
-94.28%
5Y Avg
-90.35%
Market Cap
$11.06M
Return on Equity (ROE)
N/A
TTM Avg
216.74%
3Y Avg
-5384.23%
5Y Avg
-3626.91%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | $11.29M | -102.40% | -72.60% | -118.83% | -104.53% |
| Biofrontera Inc. (BFRI)vs › | $11.75M | -106.87% | -250.57% | -230.96% | -240.83% |
| IRIDEX Corporation (IRIX)vs › | $12.03M | -97.47% | -90.15% | -205.18% | -136.35% |
| Cerenome, Inc. (CNSY)vs › | $11.22M | -477.54% | -207.60% | 64.51% | -22.91% |
| Caring Brands, Inc. (CABR)vs › | $11.27M | -506.63% | -300.20% | -300.20% | -300.20% |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.19M | -276.21% | -134.62% | -196.35% | -146.45% |
| BioVie Inc. (BIVI)vs › | $11.01M | -214.92% | -46.13% | -156.76% | -652.77% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.12M | -65.18% | -26.62% | -94.28% | -90.35% |
| Pluri Inc. (PLUR)vs › | $11.06M | N/A | 216.74% | -5384.23% | -3626.91% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.17M | -85.82% | -222.53% | -140.00% | -73.12% |
ROE
-102.4%
ROA
-90.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -102.40% |
| 2026-03-31 | -66.41% |
| 2025-12-31 | -43.17% |
| 2025-09-30 | -80.83% |
| 2025-06-30 | -70.18% |
| 2025-03-31 | -55.59% |
| 2024-12-31 | -151.39% |
| 2024-09-30 | -150.00% |
| 2024-06-30 | -229.92% |
| 2024-03-31 | -167.34% |
| 2023-12-31 | -140.05% |
| 2023-09-30 | -161.68% |
| 2023-06-30 | -125.79% |
| 2023-03-31 | -170.15% |
| 2022-12-31 | -105.90% |
| 2022-09-30 | -90.19% |
| 2022-06-30 | -72.73% |
| 2022-03-31 | -64.38% |
| 2021-12-31 | -60.58% |
| 2021-09-30 | -48.71% |
| 2021-06-30 | -37.67% |
| 2021-03-31 | -31.37% |
| 2020-12-31 | -67.56% |
| 2020-09-30 | -58.19% |
| 2020-06-30 | -49.50% |
| 2020-03-31 | -76.26% |
| 2019-12-31 | -154.98% |
| 2019-09-30 | -104.87% |
| 2019-06-30 | -75.97% |
| 2019-03-31 | -62.08% |
| 2018-12-31 | -54.21% |
| 2018-09-30 | -436.29% |
| 2018-06-30 | -263.39% |
| 2017-12-31 | -679.32% |
| 2017-09-30 | -372.86% |
| 2017-06-30 | -210.97% |
| 2017-03-31 | -148.21% |
| 2016-12-31 | -82.86% |
| 2016-09-30 | -305.37% |
| 2016-06-30 | -192.33% |
| 2016-03-31 | -136.76% |
| 2015-12-31 | -114.99% |
| 2015-09-30 | -89.84% |
| 2015-06-30 | -73.27% |
| 2015-03-31 | -374.25% |
| 2014-12-31 | -320.58% |
| 2014-09-30 | -190.64% |
| 2014-06-30 | -134.97% |
| 2014-03-31 | -141.69% |
| 2013-12-31 | -423.41% |
| 2013-09-30 | -285.60% |
| 2013-06-30 | -293.58% |
| 2013-03-31 | -312.29% |
